<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-cancers-12-00713">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Herold</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Rudd</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Ljungblad</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Sanjiv</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Myrberg</surname>
    <given-names>I.H.</given-names>
   </name>
   <name>
    <surname>Paulin</surname>
    <given-names>C.B.J.</given-names>
   </name>
   <name>
    <surname>Heshmati</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hagenkort</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kutzner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Page</surname>
    <given-names>B.D.G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies</article-title>
  <source>Nat. Med.</source>
  <year>2017</year>
  <volume>23</volume>
  <fpage>256</fpage>
  <lpage>263</lpage>
  <pub-id pub-id-type="doi">10.1038/nm.4265</pub-id>
  <pub-id pub-id-type="pmid">28067901</pub-id>
 </element-citation>
</ref>
